Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;70(2):78-85.
doi: 10.3322/caac.21599. Epub 2020 Feb 26.

Metastatic melanoma

Ragini R Kudchadkar  1 , Michael C Lowe  2 , Mohammad K Khan  3 , Stephanie M McBrien  1
Affiliations
Free article
Review

Metastatic melanoma

Ragini R Kudchadkar et al. CA Cancer J Clin. 2020 Mar.
Free article
No abstract available

PubMed Disclaimer

References

    1. Sade-Feldman M, Yizhak K, Bjorgaard SL, et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell. 2019;176(1-2):404. doi:10.1016/j.cell.2018.12.034
    1. Tawbi HA, Forsyth PA, Algazi A, et al. Combined nivolumab and ipilimumab in melanoma metastatic to the brain. N Engl J Med. 2018;379:722-730.
    1. Long GV, Atkinson V, Lo S, et al. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study. Lancet Oncol. 2018;19:672-681.
    1. Tawbi HAH, Forsyth PAJ, Hodi FS, et al. Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204) [abstract]. J Clin Oncol. 2019;37(15 suppl):9501.
    1. Goldberg SB, Gettinger SN, Mahajan A, et al. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Lancet Oncol. 2016;17:976-983.

LinkOut - more resources